The project is developing a new cryoprobe that combines light and freezing technology to enable more precise treatment of eye conditions, such as retinal detachment. The probe is designed for use outside of the operating room, minimizing damage to healthy tissue and improving treatment outcomes.
The main objectives are to secure patent rights, develop a functional prototype, and achieve technical validation. Collaboration with development partners and industry players will ensure commercialization and implementation. The technology has the potential to reduce treatment costs and improve access to eye care globally.
The project has succeeded in developing a novel cryoprobe design, represented by a light-guided prototype. This is now ready for continued refinements and testing in vivo. We have also engaged commercial players in discussion, and potentially found a good fit for a future exit. We have yet to develop a device that can be tested in humans, and this work is planned for a future Proof of Concept project, along with regulatory development of the device. The project succeeded in submitting a patent application suited to facilitate commercial development of a novel light-guided cryoprobe device.